Torrent Group, founded in 1959 by U. N. Mehta and now led by Sudhir Mehta and Samir Mehta, is a major player in healthcare and power. Through Torrent Pharmaceuticals, Torrent Power, and Torrent Gas, the group continues to transform lives with innovation and sustainability.
Content:
- Torrent Group’s Company Overview and History
- Torrent Group Financials and Shareholder Returns
- How Torrent Group Started and the Growth of Its First Business
- How Did Torrent Group Expand into Subsequent Business Sectors?
- Torrent Group Revenue Split – How It Earns Across Different Sectors
- Challenges Faced by Torrent Group Across Its Businesses
- How Does Torrent Group’s Future Look in Terms of Growth and Strategy?
- How To Invest In Torrent Group Stock?
- Torrent Group Overview and Revenue Split – Quick Summary
- Torrent Group Stock And Its Revenue Across Business Segments – FAQs
Torrent Group’s Company Overview and History
Torrent Group, founded in 1959 by U. N. Mehta, has grown into a leading conglomerate in healthcare and power. Led by Sudhir Mehta and Samir Mehta, it operates major companies like Torrent Pharmaceuticals and Torrent Power, holding a significant market presence.
Torrent Group ranks among India’s top pharmaceutical and energy firms with a multibillion-dollar valuation. Torrent Pharmaceuticals is a major player in the global pharma sector, while Torrent Power is a key contributor to India’s energy landscape, driving innovation and sustainability.
Torrent Group Financials and Shareholder Returns
Torrent Pharmaceuticals Ltd, a flagship company of Torrent Group, recorded ₹10,785.80 crore in revenue and ₹1,656.40 crore in net profit for FY 2024. It maintains a 0.86% dividend yield, with returns of 25.50% over one year and 31.90% over three years.
| Metric | Value |
| Revenue (FY 2024) | ₹10,785.80 crore |
| Net Profit (FY 2024) | ₹1,656.40 crore |
| Dividend Yield | 0.86% |
| Return over 1 year | 25.50% |
| Return over 3 years | 31.90% |
| Return over 5 years | 25.60% |
How Torrent Group Started and the Growth of Its First Business
Torrent Group began its journey in 1959 when Late Mr. U. N. Mehta, a visionary medical representative, founded the company with a focus on niche pharmaceutical marketing. During that era, India’s healthcare sector was still developing, with limited access to quality medicines. Torrent Pharma emerged as a key player in bridging this gap by delivering innovative and accessible healthcare solutions.
Over the decades, the company expanded significantly, becoming a major pharmaceutical leader. Today, Torrent Pharmaceuticals Ltd is managed by Mr. Sudhir Mehta and Mr. Samir Mehta, who continue to drive its growth. The group has also diversified into the power sector, maintaining a strong presence in both industries.
Below is a chart showcasing the current revenue of Torrent Pharmaceuticals Ltd:
How Did Torrent Group Expand into Subsequent Business Sectors?
Torrent Group, initially focused on pharmaceuticals, strategically expanded into the power sector and other industries, strengthening its presence in essential services. Over the years, it has diversified while maintaining excellence and innovation in its core businesses.
- 1989 – Entered the power sector by acquiring Mahendra Electricals, renamed as Torrent Cables Ltd.
- 1996 – Acquired management control of Surat Electricity Company and laid the foundation for GTEC.
- 1998 – Acquired management control of The Ahmedabad Electricity Company.
- 2002 – Started work on a 1,147.5 MW combined cycle mega power project near Surat.
- 2004 – Unified its power businesses under the brand Torrent Power.
- 2005 – Awarded the distribution franchise for Bhiwandi Circle, Maharashtra.
- 2006 – SUGEN Power Project received “Mega Power Project” status from the Ministry of Power.
- 2007 – SUGEN registered for Clean Development Mechanism benefits by the UNFCCC.
- 2008 – Awarded distribution franchises for Agra and Kanpur.
- 2009 – Successfully commissioned the 1,147.5 MW SUGEN Mega Power Project.
- 2010 – Commenced operations as a distribution franchise for Agra, UP.
- 2011 – Commissioned its first 49.6 MW wind power plant in Gujarat.
- 2012 – SUGEN received the “Sword of Honour” from the British Safety Council.
- 2013 – Commissioned the 382.5 MW UNOSUGEN Power Project.
- 2014 – Developed a 51 MW solar power plant at Charanka Solar Park, Gujarat.
- 2015 – Launched “Torrent Power Connect” mobile app and web portal.
- 2018 – Granted a distribution license for Dholera Special Investment Region.
- 2019 – Unosugen power plant started operating under a 278 MW long-term PPA.
- 2021 – Acquired 156 MW wind power plants and 75 MW solar power projects.
- 2022 – Took over power distribution in Dadra & Nagar Haveli, Daman & Diu.
- 2023 – Began work on a green hydrogen pilot project and launched public EV charging stations.
- 2024 – Signed an MoU with the Maharashtra government for 5,700 MW pumped storage hydro projects.
Torrent Group Revenue Split – How It Earns Across Different Sectors
Torrent Group operates across various Sectors, each contributing uniquely to its revenue. Here’s an overview:
- Torrent Pharmaceuticals Ltd.: Torrent Pharmaceuticals Ltd. is a leading pharmaceutical company specializing in branded and generic medicines across multiple therapeutic areas. With a revenue of ₹10,785.80 crore in March 2024, it continues to expand globally, focusing on innovation, research, and high-quality healthcare solutions.
- Torrent Power Ltd.: Torrent Power Ltd. is a key player in the Indian power sector, engaged in generation, transmission, and distribution. Generating ₹27,527.50 crore in revenue in March 2024, it focuses on renewable energy expansion, smart grids, and sustainable electricity solutions to meet growing demands.
Challenges Faced by Torrent Group Across Its Businesses
The main challenges faced by Torrent Group include regulatory hurdles, intense competition, rising operational costs, and sustainability concerns. These factors impact profitability and require strategic adaptations to maintain growth in the pharmaceutical and power sectors while ensuring compliance, efficiency, and innovation.
- Regulatory Hurdles: Adapting to evolving government policies and industry regulations demands continuous investments in compliance, quality control, and legal frameworks, increasing operational complexity and financial burdens for the group.
- Intense Competition: Both pharmaceuticals and power sectors face strong competition from domestic and global players, necessitating constant innovation, market expansion, and strategic partnerships to sustain growth and maintain a competitive edge.
- Rising Operational Costs: Inflation, supply chain disruptions, and fluctuating raw material prices drive up costs. Torrent Group must optimize resource utilization and improve cost efficiency while ensuring product affordability and service reliability.
- Sustainability Concerns: Transitioning to renewable energy and sustainable practices requires significant investment. Meeting environmental goals while maintaining profitability is a challenge, demanding innovation in energy efficiency and eco-friendly solutions.
How Does Torrent Group’s Future Look in Terms of Growth and Strategy?
The main focus of Torrent Group’s future growth lies in strategic expansion, innovation, and sustainability. By leveraging advanced technology, optimizing operations, and exploring new markets, the group aims to strengthen its presence in the pharmaceuticals and power sectors while ensuring long-term profitability.
- Strategic Expansion: Torrent Group plans to enter new domestic and international markets, boosting revenue streams and enhancing its competitive position in the pharmaceutical and power sectors.
- Innovation & R&D: Significant investments in research and development will drive new product launches and technological advancements, ensuring continuous growth and leadership in highly competitive industries.
- Operational Efficiency: Cost optimization, automation, and streamlined supply chains will improve profitability, helping the company navigate economic fluctuations and industry challenges effectively.
- Sustainability Initiatives: Aiming for eco-friendly operations, the group is focusing on renewable energy projects and reducing carbon footprints, aligning with global environmental goals and future industry standards.
How To Invest In Torrent Group Stock?
If you are looking to invest in Torrent Group stock, you can easily do so through Alice Blue, where purchasing stocks is absolutely free with zero brokerage on equity delivery trades.
Step 1: Open a Demat & Trading Account
- Visit Alice Blue’s website
- Click on “Open Demat Account” and complete the registration.
- Upload your PAN, Aadhaar, and bank details for verification.
Step 2: Add Funds to Your Trading Account
- Log in to Alice Blue and go to the Funds section.
- Add money via UPI, Net Banking, or NEFT/RTGS for smooth transactions.
Step 3: Search & Analyze Torrent Group Stock
- Use the search bar to find Torrent Group shares.
- Check the market price, charts, and company details before investing.
Step 4: Place Your Buy Order
- Click Buy and choose Market Order (instant purchase) or Limit Order (buy at your set price).
- Enter the quantity and confirm your order.
Torrent Group Overview and Revenue Split – Quick Summary
- Founded in 1959, Torrent Group, led by Sudhir and Samir Mehta, is a major player in healthcare and power. It holds a strong market presence with Torrent Pharmaceuticals and Torrent Power driving growth and innovation.
- Torrent Pharmaceuticals Ltd, a key Torrent Group company, reported ₹10,785.80 crore revenue and ₹1,656.40 crore net profit in FY 2024, with steady returns and a 0.86% dividend yield, showcasing strong financial performance.
- Torrent Pharmaceuticals Ltd has shown steady revenue growth, reaching ₹10,785.80 crore in FY 2024 from ₹8,704.60 crore in FY 2022, reflecting strong market performance and expansion in the pharmaceutical sector.
- Torrent Group expanded into the power sector in 1989-90 and acquired Ahmedabad Electricity in 1998-99. It commissioned major projects like SUGEN (2009-10) and DGEN (2014-15), later venturing into renewables and EV charging (2023-24).
- Torrent Group operates in pharmaceuticals and power sectors. Torrent Pharmaceuticals earned ₹10,785.80 crore in March 2024, while Torrent Power generated ₹27,527.50 crore, focusing on innovation, sustainability, and expansion in their respective industries.
- Torrent Group faces challenges like regulatory hurdles, intense competition, rising operational costs, and sustainability concerns. Adapting to regulations, managing costs, innovating, and ensuring eco-friendly operations are crucial for maintaining growth and competitiveness in the pharmaceuticals and power sectors.
- Torrent Group focuses on expansion, innovation, and sustainability to drive future growth. With strategic market entry, R&D investments, operational efficiency, and eco-friendly initiatives, it aims for long-term profitability in pharmaceuticals and power sectors.
- Open a free demat account with Alice Blue in 15 minutes today! Invest in Stocks, Mutual Funds, Bonds & IPOs for Free. Also, trade at just ₹ 20/order brokerage on every order.
Torrent Group Stock And Its Revenue Across Business Segments – FAQs
Torrent Group generates significant revenue from its key businesses. Torrent Pharmaceuticals reports an annual revenue of ₹10,785.80 crore, while Torrent Power contributes ₹27,527.50 crore. These divisions drive the group’s overall financial strength and market position across the healthcare and energy sectors.
Torrent Group is a diversified conglomerate with major interests in pharmaceuticals and power. It operates Torrent Pharmaceuticals in healthcare and Torrent Power in energy, focusing on innovation, sustainability, and expanding its presence across multiple markets.
Torrent Group is owned by the Mehta family, with Sudhir Mehta and Samir Mehta playing key leadership roles. Under their guidance, the group has grown into a major force in pharmaceuticals and power sectors, ensuring steady expansion.
Torrent Group operates primarily in pharmaceuticals and power. Torrent Pharmaceuticals is a leading player in the healthcare industry, while Torrent Power manages electricity generation, distribution, and renewable energy projects, contributing significantly to India’s energy infrastructure and sustainability goals.
Torrent Group generates an annual revenue of approximately ₹38,313 crore, combining its key businesses—Torrent Pharmaceuticals, which contributes around ₹10,786 crore, and Torrent Power, which generates about ₹27,528 crore. The group continues expanding across healthcare and energy sectors with a strong growth focus.
Torrent Power contributes the most to Torrent Group’s revenue, generating approximately ₹27,528 crore annually. This accounts for a significant share of the group’s total revenue, driven by its presence in power generation, transmission, and distribution across multiple regions in India.
Torrent Pharmaceuticals Ltd has shown steady stock performance over the years. Over the past year, it delivered a 25.50% return, while the three-year return stood at 31.90%. Over five years, the stock gained 25.60%, reflecting consistent long-term growth.
Torrent Group, through its key listed entity Torrent Pharmaceuticals Ltd, has issued bonus shares in the past. However, such issuances are not frequent and depend on the company’s financial strategy, profitability, and board decisions at any given time.
The major shareholders of Torrent Pharmaceuticals Ltd, a key entity of Torrent Group, include promoters holding 68.30%, foreign institutional investors (FIIs) with 16.20%, domestic institutional investors (DIIs) at 8.40%, and the public holding 7.20% as of December 2024.
Torrent Group recently acquired a 67% majority stake in the IPL franchise Gujarat Titans (Irelia Sports India Private Limited) from Irelia Company Pte Ltd, previously owned by private equity fund CVC, strengthening its presence in the sports and entertainment sector.
Disclaimer: The above article is written for educational purposes and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
